In 1984, the New England Journal of Medicine ( NEJM ) began requiring authors of research papers to disclose financial relationships with the pharmaceutical or device industry. The policy was controversial then, and even a decade later still faced criticism...
Filed under: Physicians, Quality, Research, Featured, Costs and Spending, Drugs and Medical Technology, Health Professionals, NIH, FDA, Industry, Science, NEJM, Cochrane, scientific funding, BMJ, Christopher Robertson